for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Chemed Corporation

CHE.N

Latest Trade

425.26USD

Change

2.08(+0.49%)

Volume

31,808

Today's Range

422.54

 - 

427.35

52 Week Range

263.64

 - 

440.76

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
423.18
Open
424.11
Volume
31,808
3M AVG Volume
2.54
Today's High
427.35
Today's Low
422.54
52 Week High
440.76
52 Week Low
263.64
Shares Out (MIL)
15.84
Market Cap (MIL)
6,737.79
Forward P/E
30.74
Dividend (Yield %)
0.30

Next Event

Q3 2019 Chemed Corp Earnings Release

Latest Developments

More

Chemed Sees FY 2019 Adjusted Earnings Per Share $13.65 To $13.85 Excluding Items

Roto-Rooter To Buy Assets Of Its Largest Independent Franchise Operator

Chemed Corporation Declares Quarterly Dividend Of 32 Cents

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Chemed Corporation

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry

Healthcare Facilities

Contact Info

255 E 5th St Ste 2600

+1.513.7626690

http://www.chemed.com

Executive Leadership

George J. Walsh

Independent Chairman of the Board

Kevin J. McNamara

President, Chief Executive Officer, Director

David Patrick Williams

Chief Financial Officer, Executive Vice President

Spencer S. Lee

Executive Vice President

Nicholas Michael Westfall

Executive Vice President

Key Stats

2.00 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

1.6K

2017

1.7K

2018

1.8K

2019(E)

1.9K
EPS (USD)

2016

7.240

2017

8.430

2018

11.930

2019(E)

13.768
Price To Earnings (TTM)
35.00
Price To Sales (TTM)
3.67
Price To Book (MRQ)
10.84
Price To Cash Flow (TTM)
27.92
Total Debt To Equity (MRQ)
16.25
LT Debt To Equity (MRQ)
13.74
Return on Investment (TTM)
24.63
Return on Equity (TTM)
19.88

Latest News

BRIEF-Chemed Corp Q1 GAAP Earnings Per Share $2.66

* Q1 EARNINGS PER SHARE VIEW $2.36 -- THOMSON REUTERS I/B/E/S

BRIEF-Chemed Corp Says CEO Kevin McNamara's FY 2017 Total Compensation Was $7.9 Mln

* CHEMED CORP SAYS PRESIDENT AND CEO KEVIN MCNAMARA'S FY 2017 TOTAL COMPENSATION WAS $7.9 MLN VS $6.5 MLN IN FY 2016 - SEC FILING Source text: (http://bit.ly/2Hstd1Z) Further company coverage:

BRIEF-Chemed Corporation’s Board Authorizes Additional $150 Million For Stock Repurchase

* CHEMED CORPORATION’S BOARD OF DIRECTORS AUTHORIZES AN ADDITIONAL $150 MILLION FOR STOCK REPURCHASE

BRIEF-Chemed Q4 GAAP Earnings Per Share $3.25

* SEES FY 2018 ADJUSTED EARNINGS PER SHARE $10.60 TO $10.85 EXCLUDING ITEMS

BRIEF-Chemed reaches final agreement to end civil litigation & false claims act brought by U.S. DOJ in May 2013​

* Chemed - Reached final agreement to end civil litigation and false claims act brought by U.S. Department of Justice in May 2013

Chemed to pay $75 million over false claims lawsuit: Justice Dept

Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

BRIEF-Chemed reports Q3 earnings per share $2.13

* Sees FY 2017 adjusted earnings per share $8.35 to $8.40 excluding items

BRIEF-Chemed Corp increases quarterly dividend 7.7 pct

* Says declared quarterly cash dividend of 28-cents per share Source text for Eikon: Further company coverage:

BRIEF-Chemed Corp qtrly ‍adjusted diluted eps $2.15​

* Chemed Corp qtrly net patient revenue of $285 million, an increase of 2.1%

BRIEF-Chemed reports Q1 GAAP earnings per share $1.78

* Says revenue growth for vitas in 2017, prior to medicare cap, is estimated to be in range of 4% to 5%

BRIEF-Chemed Corp CEO Kevin Mcnamara's 2016 compensation $6.5 mln

* Chemed corp - ceo kevin mcnamara's total compensation for 2016 was $6.5 million versus $7.4 million in 2015 - sec filing Source text for Eikon: Further company coverage:

BRIEF-Chemed Corp board authorizes an additional $100 mln for stock repurchase

* Chemed Corp's board of directors authorizes an additional $100 million for stock repurchase

BRIEF-CHEMED SETS QUARTERLY DIVIDEND OF $0.26 PER SHARE

* SETS QUARTERLY DIVIDEND OF $0.26 PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Chemed reports Q3 adj earnings per share of $1.73

* Sees fy 2016 adjusted earnings per share $7.20 to $7.30 excluding items

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up